View drug registration information details.


ItemsRegistration information
ID321
No321
Brand NameHOVID TENOFOVIR DISOPROXIL FUMARATE TABLETS 300 MG
IngredientsTENOFOVIR DISOPROXIL FUMARATE 300 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
StorageSTORE BELOW 30C
Shelf Life3 YEARS
Pack SizeBOX OF 30'S
Dispensing CategoryPrescription only
ATC Classification
Pharmaceutical ClassANTIVIRAL
IndicationsFOR THE TREATMENT OF HIV-1 INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL MEDICINAL PRODUCT FOR ADULTS, TREATMENT OF HIV-1 INFECTED ADOLESCENTS WITH NRTI RESISITANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS, AGED 12 TO <18 YEARS, FORO THE TREATMENT OF CHRONIC HEPATITIS B IN ADULT AND ADOLESCENT 12 - <18 YEARS OF AGE.
ContraindicationsHYPERSENSITIVITY
Side EffectsHYPOPHOSPHATAEMIA, DIZZINESS, HEADACHE, DIARRHEA, VOMITING, NAUSEA, ABDOMINAL PAIN, ABDOMINAL DISTENSION, FLATULENCE, INCREASED TRANSAMINASES, RASH, ASTHENIA
Unit Price
EDL Yes
DescriptionWHITE, OBLONG, FILM COATED TABLET, EMBOSSED WITH QZ ON BOTH SIDES OF TABLETS
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO.,LTD
CountryCHINA
Import Registration NoGYZZ H20173303
Import Registration Date39-09-2017
ActivityCERTIFICATE RELEASED
Applied Date2021-09-07
FDD Registration No01 I 5391/23
FDD Registration Date2023-01-23
Expiry Date2026-01-22

Back to drug list